Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Lambert

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Thrombosis Research|March 12, 2014
Joint disease, the hallmark of haemophilia: what issues and challenges remain despite the development of effective therapies?Thierry Lambert, Günter Auerswald, Gary Benson, et al.
Mbio|October 23, 2014
Origin in Acinetobacter guillouiae and dissemination of the aminoglycoside-modifying enzyme Aph(3')-VIEun-Jeong Yoon, Sylvie Goussard, Marie Touchon, et al.
Fetal Diagnosis and Therapy|June 12, 2004
Reappraisal of in utero stem cell transplantation based on long-term resultsJean-Louis Touraine, Daniel Raudrant, François Golfier, et al.
Journal of the American Geriatrics Society|October 3, 2007
Acquired hemophilia in older people: a poor prognosis despite intensive careOlivier Lambotte, Justine Dautremer, Benoît Guillet, et al.
Research and Practice in Thrombosis and Haemostasis|June 23, 2025
Inhibitor development in nonsevere hemophilia: data from the European Haemophilia Safety Surveillance (EUHASS) registryKathelijn Fischer, Riitta Lassila, Flora Peyvandi, et al.
Blood|January 5, 2002
Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia ATon Lisman, Laurent O Mosnier, Thierry Lambert, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 20, 2021
Practical considerations for nonfactor-replacement therapies in the treatment of haemophilia with inhibitorsVictor Jiménez-Yuste, Günter Auerswald, Gary Benson, et al.
Hepatology (Baltimore, Md.)|October 23, 2021
In vitro recovery of FIX clotting activity as a marker of highly functional hepatocytes in a hemophilia B iPSC modelEléanor Luce, Clara Steichen, Mickaël Allouche, et al.
Thrombosis and Haemostasis|August 22, 2015
Inhibitor development in non-severe haemophilia across EuropeKathelijn Fischer, Alfonso Iorio, Riitta Lassila, et al.
Journal of Thrombosis and Haemostasis : JTH|January 21, 2019
Clinical pharmacology, efficacy and safety study of a triple-secured fibrinogen concentrate in adults and adolescent patients with congenital fibrinogen deficiencyClaudia Djambas Khayat, Mohamed El Khorassani, Thierry Lambert, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Thrombosis Research|March 12, 2014
Joint disease, the hallmark of haemophilia: what issues and challenges remain despite the development of effective therapies?Thierry Lambert, Günter Auerswald, Gary Benson, et al.
Mbio|October 23, 2014
Origin in Acinetobacter guillouiae and dissemination of the aminoglycoside-modifying enzyme Aph(3')-VIEun-Jeong Yoon, Sylvie Goussard, Marie Touchon, et al.
Fetal Diagnosis and Therapy|June 12, 2004
Reappraisal of in utero stem cell transplantation based on long-term resultsJean-Louis Touraine, Daniel Raudrant, François Golfier, et al.
Journal of the American Geriatrics Society|October 3, 2007
Acquired hemophilia in older people: a poor prognosis despite intensive careOlivier Lambotte, Justine Dautremer, Benoît Guillet, et al.
Research and Practice in Thrombosis and Haemostasis|June 23, 2025
Inhibitor development in nonsevere hemophilia: data from the European Haemophilia Safety Surveillance (EUHASS) registryKathelijn Fischer, Riitta Lassila, Flora Peyvandi, et al.
Blood|January 5, 2002
Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia ATon Lisman, Laurent O Mosnier, Thierry Lambert, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 20, 2021
Practical considerations for nonfactor-replacement therapies in the treatment of haemophilia with inhibitorsVictor Jiménez-Yuste, Günter Auerswald, Gary Benson, et al.
Hepatology (Baltimore, Md.)|October 23, 2021
In vitro recovery of FIX clotting activity as a marker of highly functional hepatocytes in a hemophilia B iPSC modelEléanor Luce, Clara Steichen, Mickaël Allouche, et al.
Thrombosis and Haemostasis|August 22, 2015
Inhibitor development in non-severe haemophilia across EuropeKathelijn Fischer, Alfonso Iorio, Riitta Lassila, et al.
Journal of Thrombosis and Haemostasis : JTH|January 21, 2019
Clinical pharmacology, efficacy and safety study of a triple-secured fibrinogen concentrate in adults and adolescent patients with congenital fibrinogen deficiencyClaudia Djambas Khayat, Mohamed El Khorassani, Thierry Lambert, et al.
Pageof 8